BC
SLDB icon

Boxer Capital’s Solid Biosciences SLDB Stock Holding History

Boxer Capital’s Portfolio SLDB Stock Details SLDB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-355,735
Closed -$3.29M – 80
2022
Q2 		$3.29M Hold
355,735
– – 0.21% 62
2022
Q1 		$6.4M Buy
355,735
+143,888
+68% +$2.54M 0.33% 49
2021
Q4 		$5.56M Sell
211,847
-37,125
-15% -$1.13M 0.22% 54
2021
Q3 		$8.93M Sell
248,972
-33,333
-12% -$1.42M 0.31% 64
2021
Q2 		$15.5M Hold
282,305
– – 0.55% 55
2021
Q1 		$23.4M Hold
282,305
– – 0.79% 39
2020
Q4 		$32.1M Buy
282,305
+180,180
+176% +$11.4M 1.03% 26
2020
Q3 		$3.11M Hold
102,125
– – 0.11% 72
2020
Q2 		$4.49M Hold
102,125
– – 0.2% 59
2020
Q1 		$3.66M Buy
102,125
+33,334
+48% +$1.65M 0.25% 53
2019
Q4 		$4.59M Sell
68,791
-191,000
-74% -$21.1M 0.26% 45
2019
Q3 		$40.3M Buy
259,791
+28,240
+12% +$3.2M 2.92% 11
2019
Q2 		$20M Hold
231,551
– – 1.72% 19
2019
Q1 		$32M Sell
231,551
-1,667
-0.7% -$418K 3.7% 13
2018
Q4 		$93.8M Buy
233,218
+41,111
+21% +$19.3M 11.58% 2
2018
Q3 		$136M Buy
192,107
+6,774
+4% +$4.26M 15.09% 1
2018
Q2 		$99.1M Buy
185,333
+135,333
+271% +$41.6M 11.22% 1
2018
Q1 		$5.63M Buy
+50,000
New +$16.9M 0.6% 25

Other funds holding SLDB

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
KPF
K2 Principal Fund Toronto, Ontario, Canada $1.43B AUM 29.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

Boxer Capital's SLDB Position: Q3 2022 in Review

Boxer Capital sold out of Solid Biosciences (SLDB) in Q3 2022, closing a stake of 355,735 shares — an estimated $3.29M sold.

Boxer Capital first reported a position in SLDB in Q1 2018 and held it in 18 quarters. The position peaked at $136M in Q3 2018. 58 funds tracked by Wall St. Rank hold SLDB as of Q3 2022.

  • Boxer Capital reported no remaining Solid Biosciences position as of Q3 2022 after selling out during the quarter.
  • Boxer Capital sold 355,735 Solid Biosciences shares in Q3 2022, an estimated $3.29M.
  • Boxer Capital first reported a position in Solid Biosciences in Q1 2018 and held it in 18 quarters.
  • Boxer Capital's Solid Biosciences position peaked at $136M in Q3 2018.
  • 58 funds tracked by Wall St. Rank held Solid Biosciences as of Q3 2022.

Based on Boxer Capital's 13F filing for Q3 2022, filed 14 Nov 2022.